Interested in specific subtype?

Filter what you see here

DLBCL

Quick poll

Ibrutinib plus R-CHOP for non-germinal center DLBCL: Results from a phase…

Ibrutinib plus R-CHOP for non-germinal center DLBCL: Results from a phase III trial

Closes Apr 13, 2019

DLBCL,   FL

Quick poll

Polatuzumab or pinatuzumab vedotin plus rituximab for R/R NHL: Results…

Closes Apr 12, 2019

MZL,   FL

Quick poll

Results from the AUGMENT phase III trial: Lenalidomide + rituximab for R/R…

Closes Apr 11, 2019

DLBCL

Quick poll

EBMT Debate Session | How to treat R/R DLBCL in 2019? | Part 3 –…

EBMT Debate Session | How to treat R/R DLBCL in 2019? | Part 3 – CAR-T

Closes Apr 5, 2019

DLBCL

Quick poll

EBMT Debate Session | How to treat R/R DLBCL in 2019? | Part 2 –…

Closes Apr 4, 2019

DLBCL

Quick poll

EBMT Debate Session | How to treat R/R DLBCL in 2019? | Part 1 - ASCT

Closes Apr 4, 2019

DLBCL

Quick poll

EBMT 2019 | A consensus grading system for toxicities in CAR T trials

EBMT 2019 | A consensus grading system for toxicities in CAR T trials

Closes Apr 1, 2019 , Expert Opinion

HL

Quick poll

Chiara De Philippis | EBMT 2019 | Impact of checkpoint inhibitors on…

Closes Apr 1, 2019

HL

Quick poll

EBMT 2019 | Donor lymphocyte infusion monotherapy for HL after allo-SCT…

Closes Mar 29, 2019

DLBCL,   BL,  CLL/SLL

Quick poll

EBMT 2019 | Preliminary in-human evaluation of a CD19/CD22 dual CAR-T…

EBMT 2019 | Preliminary in-human evaluation of a CD19/CD22 dual CAR-T construct for B-NHL

Closes Mar 28, 2019

DLBCL

Quick poll

Marie José Kersten | EBMT 2019 | CAR T cells vs autologous SCT vs…

Closes Mar 28, 2019

HL

Quick poll

EBMT 2019 | Tandem autologous-reduced-intensity allogeneic SCT for R/R HL

Closes Mar 27, 2019
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (CLL)

Latest Medical Information

Latest Biology

English & French

Latest Drug Updates

Congress Coverage

Recently updated Licenses

Where we are next

ASCO Annual Meeting 2019

May 31 – June 4, 2019 | Chicago, USA

The Lymphoma Hub will be attending the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, US, May 31– June 4, 2019. The meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates on the hottest topics in oncology. Stay tuned to follow our first-hand coverage.

#lymsm

Event Website

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology